Novo Nordisk AS (NVO.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec22

Novo Nordisk's Weight-Loss Semaglutide Injection Cardiovascular Indication Approved in China

09:31

Analysis from Cmoney suggests Novo Nordisk's valuation may be underestimated

08:52

Concerns grow in South Korea over excessive use and side effects of Wegovy

00:00

Dec21

Novo Nordisk to participate in the European Congress on Obesity (ECO) 2026

17:40

R&D progress of oral weight-loss drug becomes a key potential catalyst for Novo Nordisk's stock in 2026

12:01

Novo Nordisk seeks USFDA approval for once-weekly CagriSema for weight management

11:00

Schedules & Filings

Schedules

Filings

Feb4

Earning Release(EST)

FY2025 Annual Earning Release

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 11.78 B, Net Income 3.143 B, EPS 0.707

Novo Nordisk A/S (NVO.US) Q3 2025 Earnings Conference Call

Aug26

Distribution Plan(EST)

Cash dividend 0.5843 USD

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change